Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriaki Mohri is active.

Publication


Featured researches published by Noriaki Mohri.


Clinical Imaging | 2009

Angle between 1 and 4 min gives the most significant difference in time–intensity curves between benign disease and breast cancer: analysis of dynamic magnetic resonance imaging in 103 patients with breast lesions

Masayasu Hara; Takeshi Watanabe; Akie Okumura; Kazuko Kato; Noriaki Mohri; Masakazu Ishikawa; Akira Mizuno; Hiromitsu Takeyama

The aim of the present study was to clarify the morphologic characteristics of time-intensity curves (TICs) that are useful for distinguishing benign from malignant lesions. One hundred three patients with breast lesions underwent dynamic breast MRI. The areas under the receiver operating characteristic (ROC) curves (AUC) from every component of TIC were compared between benign and malignant disease. As a result, angle of cross line between 1 and 4 min is more useful than rapid enhancement for distinguishing benign from malignant lesions.


Surgery Today | 1995

Perforated acute appendicitis in a patient with AIDS/HIV infection: report of a case.

Noriaki Mohri; Yoshimi Akamo; Hiromitsu Takeyama; Masashi Mizokami; Hiroyuki Yuasa; Isamu Mizuno; Nagao Shinagawa; Tadao Manabe

We report herein the case of a 40-year-old man with AIDS who was admitted to hospital with severe abdominal pain, fever, and chills. He underwent an emergency laparotomy which revealed a perforated appendix with suppurative peritonitis. An appendectomy with peritoneal drainage was carried out, but the postoperative course was complicated by fever without leukocytosis; however, he gradually improved following treatment with intravenous antibiotics, granulocyte colony-stimulating factor (G-CSF) and immunoglobulins, and made a complete recovery. His postoperative course demonstrates the effectiveness of this treatment regimen for patients with AIDS complicated by infection without an increase in the white blood cell count (WBC).


International Journal of Clinical Oncology | 2000

Arterial infusion therapy with low-dose cisplatin and continuous 5-fluorouracil for isolated hepatic recurrence of gastric carcinoma

Yoshimi Akamo; Hiromitsu Takeyama; Noriaki Mohri; Futoshi Teranishi; Tadao Manabe

Abstract Patients with metachronous liver metastasis after curative resection of gastric carcinoma generally have a poor prognosis, even when recurrence is confined to the liver. We report a patient in whom hepatic arterial infusion therapy with bolus low-dose cisplatin (CDDP) and continuous 5-fluorouracil (5-FU) was effective against large metastases confined to the liver. An 83-year-old man was admitted with huge liver metastases from gastric carcinoma. Intra-arterial bolus injection of low-dose CDDP (5 mg) and continuous intra-arterial infusion of 5-FU (250 mg/day for 7 days) was started. After four courses of this arterial infusion therapy, computed tomography scans revealed shrinkage of the liver metastases. He was followed-up as an outpatient and continued to receive the arterial infusion therapy once every 4 weeks. Throughout the course of the chemotherapy, a partial response of the liver metastases was maintained. The patient had an improved quality of life after starting the chemotherapy, and he survived for 16 months from the commencement of the therapy. Arterial infusion therapy with bolus low-dose CDDP and continuous 5-FU may be recommended for patients with isolated hepatic recurrence of gastric carcinoma.


Anticancer Research | 2006

Treatment of peritoneal carcinomatosis using carboplatin-loaded hydroxyapatite particles.

Hiromitsu Takeyama; Noriaki Mohri; Isamu Mizuno; Yoshimi Akamo; Hirozumi Sawai; Tadao Manabe; Toshihisa Yotsuyanagi; Satoshi Nakamura


Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2004

TRANSPYLORIC PROLAPSE OF ADVANCED GASTRIC CANCER WITH LIVER METASTASIS

Noriaki Mohri; Shunsuke Fukaya; Akira Yasuda; Kozo Matsumoto; Isamu Mizuno; Nagao Shinagawa


Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 2000

Multiple Granular Cell Tumors of the Colon.

Hiromitsu Takeyama; Eiko Ohara; Yoshimi Akamo; Moritsugu Tanaka; Takuji Fukui; Tetsushi Hayakawa; Noriaki Mohri; Minoru Yamamoto; Mikinori Sato; Tadao Manabe


Drug Delivery System | 1999

Intraperitoneal administration of carboplatin-loaded hydroxyapatite particles as a drug carrier in rats and prophylaxis and treatment of pleural carcinomatosis for the purpose of clinical application.

Isamu Mizuno; Noriaki Mohri; Toshihisa Yotsuyanagi; Satoshi Nakamura; Tadao Manabe


Drug Delivery System | 1996

Antitumor effect of liposome-entrapped carboplatin administrated via the portal vein in rats.

Junji Terada; Isamu Mizuno; Tadao Manabe; Toshihisa Yotsuyanagi; Noriaki Mohri


Drug Delivery System | 1994

Intraperitoneal administration of hydroxyapatite particles as a drug carrier in rats bearing carcinomatous peritonitis.

Noriaki Mohri; Isamu Mizuno; Tetsuya Yamamoto; Tomohisa Yotsuyanagi; Hideki Aoki


Asian Journal of Surgery | 2002

Successful drainage of a mediastinal abscess via an esophago-mediastinal fistula complicating radiotherapy for esophageal cancer: a case report.

Noriaki Mohri; Akamo Y; Hiromitsu Takeyama; Tadao Manabe

Collaboration


Dive into the Noriaki Mohri's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge